Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
164 hedge funds and large institutions have $895M invested in Momenta Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 35 reducing their positions, and 19 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 35
49% more call options, than puts
Call options by funds: $1.93M | Put options by funds: $1.3M
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
5% more funds holding
Funds holding: 156 → 164 (+8)
12% less capital invested
Capital invested by funds: $1.02B → $895M (-$125M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$48.2M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$11.8M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$9.07M |
| 4 |
QI
QS Investors
New York
|
+$3.51M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$90M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.06M |
| 3 |
State Street
Boston,
Massachusetts
|
-$7.28M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$7.13M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$3.74M |
MNTA Hedge Fund Activity: Q4 2015 in Review
164 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2015, worth a combined $895M — down 12% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new MNTA positions and 19 closed out — a net gain of 9 holders — while 73 added to existing stakes and 35 trimmed.
The largest buyer was Invesco, adding an estimated $48.2M. The largest seller was Visium Asset Management, cutting an estimated $90M.
- 164 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2015, up from 156 in Q3 2015.
- Funds reported $895M of Momenta Pharmaceuticals, Inc. stock for Q4 2015, down 12% quarter-over-quarter.
- 28 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2015 and 19 closed out, a net change of +9 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2015 was Invesco, an estimated $48.2M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q4 2015 was Visium Asset Management, an estimated $90M sold.
Based on aggregated 13F filings for Q4 2015.